Toyama, Eisai seek iguratimod approval in Japan

Toyama Chemical Co. Ltd (Tokyo:4518) and partner Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) submitted a regulatory application in Japan for iguratimod ( T-614) as add-on therapy to treat rheumatoid arthr...